Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey
- 1 August 2010
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 26 (8) , 861-864
Abstract
The presence of antibodies to human T-lymphotropic virus (HTLV) types 1 and 2 was examined in 5742 sera belonging to consecutive adult outpatients attended during June 2008 at 13 different hospitals across Spain. Overall, 58.8% were female. Foreigners represented 8% of the study population. Seven individuals were seropositive for HTLV-2 (overall prevalence 0.12%). No cases of HTLV-1 infection were found. All HTLV-2+ subjects were Spanish natives, of whom six were coinfected with HIV-1 and five with hepatitis C virus (HCV). Moreover, all but one of the HTLV-2+ subjects had been intravenous drug users. In summary, this cross-sectional survey suggests that the rate of HTLV infection in Spain is low, and is mostly represented by HTLV-2. Infected individuals are generally Spanish natives with a prior history of intravenous drug use and are coinfected with HIV-1 and/or HCV.Keywords
This publication has 19 references indexed in Scilit:
- Neurologic abnormalities in HTLV-I– and HTLV-II–infected individuals without overt myelopathyNeurology, 2009
- Short Communication: Hospital-Based Surveillance for HTLV-1/2 Infections in SpainAIDS Research and Human Retroviruses, 2007
- Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in SpainJournal of Medical Virology, 2006
- Natural history of adult T-cell leukemia/lymphoma and approaches to therapyOncogene, 2005
- Global epidemiology of HTLV-I infection and associated diseasesOncogene, 2005
- Human T‐lymphotropic virus type II and neurological diseaseAnnals of Neurology, 2004
- Seroepidemiology of HTLV-I/II in Argentina: An OverviewJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)The Journal of Emergency Medicine, 2000
- Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribesProceedings of the National Academy of Sciences, 1999
- Human T‐cell lymphotropic virus type II–associated myelopathy: Clinical and immunologic profilesAnnals of Neurology, 1996